— Smartsheet Inc (NYSE: SMAR) reported fourth-quarter 2020 loss of $0.13 per share, vs. $0.16 per share loss expected. — Q4 net
Smartsheet Inc (SMAR): Q4 2020 Earnings Snapshot
Categories
Earnings
MongoDB (MDB) betters Q4 2020 estimates; Q1 and FY21 revenue to be affected by COVID-19
Despite surpassing the bottom and topline estimates of the Street in Q4, MongoDB (NASDAQ: MDB) stock traded in negative territory as the
FedEx (FDX) stock rises on Q3 revenue beat; suspends FY20 outlook due to covid-19 crisis
Logistics giant FedEx Corp. (NYSE: FDX) Tuesday said its third-quarter earnings declined from last year amid continuing weakness in the core business.
What to look for when CrowdStrike (CRWD) reports Q4 earnings
CrowdStrike Holdings Inc. (NASDAQ: CRWD) is scheduled to report fourth quarter 2020 earnings results on Thursday, March 19, after the market closes.
Gevo (GEVO) posts narrower-than-expected Q4 loss
Gevo Inc. (NASDAQ: GEVO) reported a narrower loss in the fourth quarter of 2019 helped by higher revenue, lower costs and expenses
Huya’s (HUYA) stock falls despite an upbeat Q4
HUYA Inc. (NYSE: HUYA) beat revenue and earnings expectations for the fourth quarter of 2019. The consensus estimates were for earnings of
Designer Brands (DBI): Q4 2019 Earnings Snapshot
-- Designer Brands Inc. (NYSE: DBI) reported Q4 2019 loss of $0.11 per share, vs. a loss of $0.06 expected. -- Sales
Baxter International (BAX): Q4 2019 Earnings Snapshot
-- Baxter International Inc. (NYSE: BAX) reported Q4 2019 earnings of $0.97 per share, up 37% from last year. -- Worldwide sales
JOYY (NASDAQ: YY): Q4 2019 Earnings Snapshot
-- JOYY Inc. (NASDAQ: YY), which was formerly known as YY Inc., reported its fourth-quarter 2019 adjusted earnings of RMB6.70 or $0.96
Catalyst Pharmaceutical (CPRX): Q4 2019 Earnings Snapshot
-- Catalyst Pharmaceutical (NASDAQ: CPRX) reported its fourth-quarter 2019 earnings of $0.07 per share versus $0.10 per share expected. -- Total revenue
CorMedix (NYSE: CRMD): Q4 2019 Earnings Snapshot
-- CorMedix Inc. (NYSE: CRMD) reported a fourth-quarter 2019 loss of $0.21 per share versus a loss of $0.24 per share expected.
Tencent Music swings to profit in Q4 on 35% revenue growth
Tencent Music Entertainment Group (NYSE: TME), a unit of China-based internet giant Tencent Holdings, reported profit for the fourth quarter compared to
Nio (NIO) set to report Q4 earnings Wednesday. here’s what you need to know
China-based auto firm Nio Inc. (NYSE: NIO) recorded a decline in deliveries in February but the numbers came in above estimates, underscoring
AcelRx Pharmaceuticals (ACRX) Q4 2019 Earnings Snapshot
-- Specialty pharmaceutical company AcelRx Pharmaceuticals (NASDAQ: ACRX) reported fourth quarter 2019 loss of $0.18 per share vs. expected loss of $0.20 per
FuelCell beats Q1 revenue estimates; reports wider-than-expected loss
FuelCell Energy Inc. (NASDAQ: FCEL) topped revenue expectations for the first quarter of 2020 while losses were wider-than-expected. Shares were down 8%
NewAge Beverages misses Q4 revenue expectations
NewAge Beverages Corporation (NASDAQ: NBEV) missed revenue estimates for the fourth quarter of 2019 while losses were wider-than-expected. Shares were down 6.8%
New Age Beverages (NBEV) stock plunges to new 52-week low ahead of Q4 2019 earnings
New Age Beverages (NASDAQ: NBEV) is slated to release its fourth quarter and full-year 2019 results on Monday, March 16 before the
What to watch when FuelCell (FCEL) reports Q1 2020 earnings
FuelCell Energy Inc. (NASDAQ: FCEL) is slated to report first quarter 2020 earnings results on Monday, March 16, before the market opens.
A mixed Q4 awaits MongoDB (MDB) amid high costs, steady customer growth
MongoDB’s (NASDAQ: MDB) stock briefly halted the free-fall this week and stabilized ahead of the fourth-quarter earnings release, after slipping to a
ReneSola (SOL) Q4 2019 Earnings Snapshot
-- ReneSola (NYSE: SOL) reported its fourth quarter 2019 earnings of $0.09 per share vs. $0.02 per share expected. -- Revenue was
Achieve Life Sciences (ACHV): Q4 2019 Earnings Snapshot
-- Achieve Life Sciences (NASDAQ: ACHV) reported Q4 2019 net loss of $3.2 million, or $0.30 per share, compared to a loss